Stable graft function after reduction of calcineurin inhibitor dosage in paediatric kidney transplant patients | Zendy

Christian Plank | Zendy; Kerstin Benz | Zendy; Kerstin Amann | Zendy; KaiDietrich Nüsken | Zendy; Katalin Dittrich | Zendy; Wolfgang Rascher | Zendy; Katja Sauerstein | Zendy; Anja Stuppy | Zendy; B. Klare | Zendy; Jörg Dötsch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stable graft function after reduction of calcineurin inhibitor dosage in paediatric kidney transplant patients

Author(s) -

Christian Plank,

Kerstin Benz,

Kerstin Amann,

KaiDietrich Nüsken,

Katalin Dittrich,

Wolfgang Rascher,

Katja Sauerstein,

Anja Stuppy,

B. Klare,

Jörg Dötsch

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl279

Subject(s) - calcineurin , medicine , chronic allograft nephropathy , toxicity , urology , kidney disease , reduction (mathematics) , renal function , tacrolimus , kidney , kidney transplantation , transplantation , geometry , mathematics

Chronic calcineurin inhibitor (CNI) toxicity contributes to the development and progression of chronic allograft nephropathy (CAN), which is still the major cause of transplant dysfunction and graft loss. Reduction in dosage of CNI may delay the development of CAN, leading to longer graft survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research